Filtered By:
Management: Insurance
Therapy: Antiviral Therapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 21 results found since Jan 2013.
Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study
CONCLUSIONS: Initiating AVT based on detectable serum HBV-DNA provided the similar risk of postoperative HCC recurrence in HBV-infected HCC patients with and without detectable serum HBV-DNA.PMID:36347739 | DOI:10.1016/j.ejim.2022.10.026
Source: European Journal of Internal Medicine - November 8, 2022 Category: Internal Medicine Authors: Byungyoon Yun Sang Hoon Ahn Juyeon Oh Jin-Ha Yoon Beom Kyung Kim Source Type: research
Extended Duration Letermovir Prophylaxis for Cytomegalovirus Infection after Cord Blood Transplantation in Adults
Blood Adv. 2022 Jul 8:bloodadvances.2022008047. doi: 10.1182/bloodadvances.2022008047. Online ahead of print.ABSTRACTCord blood transplantation (CBT) can be complicated by a high incidence of clinically significant cytomegalovirus infection (csCMVi). We have investigated the efficacy of extended letermovir prophylaxis in seropositive adult CBT recipients. The aim was to continue prophylaxis for > 6 months (insurance permitting). By day 100, the incidence of csCMVi was 0% in 28 patients who received prophylaxis. Moreover, of 24 patients alive at day 100, none had csCMVi by day 180, having continued prophylaxis for all (n...
Source: Adv Data - July 8, 2022 Category: Epidemiology Authors: Ioannis Politikos Carmen Lau Sean M Devlin Sean Quach Andrew Lin Miguel-Angel Perales Gunjan L Shah Susan Seo Genovefa Papanicolaou Juliet N Barker Source Type: research
Effects of direct-acting antiviral therapy for patients with advanced hepatocellular carcinoma and concomitant hepatitis C-A population-based cohort study
CONCLUSIONS: The analysis of big data from the Taiwan National Health Insurance Research Database revealed that advanced HCC patients on sorafenib benefited from DAAs as a treatment for HCV infection. Patients whose HCV infection was cured had better OS.PMID:34919256 | DOI:10.26355/eurrev_202112_27454
Source: Pharmacological Reviews - December 17, 2021 Category: Drugs & Pharmacology Authors: H-Y Tsai H-P Chang C-J Chen W-L Hsu L-Y Huang P-C Lee Source Type: research
Hepatitis C-associated late-onset schizophrenia: a nationwide, population-based cohort study
CONCLUSION: In a population-based cohort (most aged ≥ 40 years), HCV positivity was a potential risk factor for the development of schizophrenia; the HCV-associated risk of schizophrenia might be reversed by interferon-based antiviral therapy.PMID:34728558 | DOI:10.1503/jpn.200154
Source: J Psychiatry Neurosc... - November 3, 2021 Category: Psychiatry Authors: Jur-Shan Cheng Jing-Hong Hu Ming-Yu Chang Ming-Shyan Lin Hsin-Ping Ku Rong-Nan Chien Ming-Ling Chang Source Type: research
